Heparin-modified graphene oxide was prepared as the carrier of anti-cancer drugs and growth factor with long-term release property, reduced cytotoxicity and improved heat stability.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: